Physician profile
Natalie Amodeo
NPI 1851990667
$2,090.53
in general payments reported to CMS, 2019-2025
12 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.06 · 2023: $157 · 2024: $818 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.48 |
| Education | $141.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $648.74 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $437.07 | 2023-2025 | Airsupra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $196.25 | 2024-2025 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $162.89 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $146.96 | 2024 | Trelegy Ellipta, Nucala, Arexvy |
| Sanofi-Aventis U.S. LLC | $141.99 | 2024-2025 | |
| Amgen INC. | $137.58 | 2023-2025 | Tezspire |
| Aerin Medical INC. | $74.47 | 2025 | |
| Novartis Pharmaceuticals Corporation | $60.73 | 2023-2024 | |
| Stryker Corporation | $29.19 | 2025 | Clarifix |
| Abbvie INC. | $28.06 | 2022 | |
| Greer Laboratories, INC. | $26.60 | 2025 | Palforzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Amodeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.